Until now, there has been just a 15% survival rate, but government researchers announced on Thursday that they have discovered a highly accurate blood test that could find ovarian cancer in its earliest stages.
"I am completely overjoyed at the potential this technology represents in being able to save lives," says Dr. David Fishman of Northwestern University.
If Dr. Fishman looks familiar, that is because he is also a graduate of Texas Tech Medical School. He says the new test works by using a computer to scan thousands of components in the blood to search out important signs of cancer.
So far, researchers have examined about 100 blood samples in the blind study not knowing whether they came from women with cancer or not. The results, amazingly, were 100% accurate in finding ovarian cancer, even in the earliest stages. Another year of study is planned involving now about 1,000 volunteers.